Copy and paste this code to insert a reference to this article in your
blog or online community profile:
Advanced Renal Cell Carcinoma: Lenvatinib Plus Pembrolizumab or Everolimus
Current Trends Gynecol Oncol 2022, 7:112. 7:2, (2022)
https://doi.org/10.4172/ctgo.1000112
Highlight
Will Display Like this:
Advanced Renal Cell Carcinoma: Lenvatinib Plus Pembrolizumab or Everolimus
Current Trends Gynecol Oncol 2022, 7:112. 7:2, (2022)
https://doi.org/10.4172/ctgo.1000112
Powered by
OMICS International